Related Experiment Video
Updated: Oct 7, 2025

09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.4K
Subacute CNS Demyelination After Treatment With Immune Checkpoint Inhibitors
Elizabeth Tan1, Heather Shaw1, Paul Nathan1
1Department of Oncology (ET, PN), and Department of Radiology (SG-R), Mount Vernon Cancer Center, London; and Medical Oncology (HS, DO), University College London Hospitals, United Kingdom.
Neurology. Clinical Practice
|January 7, 2022
Abstract
No abstract available in PubMed .

